Harmful alcohol consumption remains a major public health issue and is increasingly assessed using laboratory biomarkers in both clinical and forensic settings. Because test results may influence medical decisions, fitness-to-drive assessments, occupational evaluations in safety-sensitive professions, and legal outcomes, biomarkers used to assess alcohol consumption should provide reliable, accurate, and internationally comparable results.
This article reviews the current landscape of alcohol biomarkers and highlights the importance of analytical standardization and traceability. Particular emphasis is placed on carbohydrate-deficient transferrin (CDT), a biomarker specifically associated with chronic excessive alcohol consumption. Extensive work by the IFCC Working Group on CDT Standardization led to the development of an IFCC-recognized reference measurement procedure (RMP) and its subsequent recognition by the Joint Committee for Traceability in Laboratory Medicine (JCTLM).
As a result, CDT-IFCC is currently the only alcohol biomarker supported by an internationally recognized framework for standardization and traceability, enabling consistent, comparable, and clinically reliable results.
Test associated with this resource
Related instruments
L’automatisation compacte et économique de l’électrophorèse capillaire.
L’évolution fait la différence.
Le concentré du savoir-faire de Sebia dans un instrument à haute cadence analytique.
Solution d’électrophorèse capillaire pour répondre à vos besoins en matière de haute capacité.
Discover more resources on Chronic Alcohol Abuse
Cette section contient des informations destinées à une large diffusion et peut donc comporter des détails sur des produits ou des informations qui ne sont pas disponibles ou valables dans votre pays. Veuillez contacter votre représentant Sebia local. Informations destinées aux professionnels de santé. Lisez attentivement les instructions figurant dans les notices des réactifs et les manuels d'utilisation des instruments.